Metraipolis › archive › dc_6a2e09f40dec

Optimal Duration of Adjuvant Platinum-Etoposide in High-Risk Merkel Cell Carcinoma — Europe PMC PMID:42195135

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42195135
DOI
10.3390/medicina62050882
License (as archived)
solo-consultazione
Archived
2026-11-02T19:19:44.411Z
SHA-256 of the archived text
10659528d3101857c7b9acecb590e862d5110a8ffca4641e882ab55b632c552b
Stable URL of this page
https://metraipolis.com/documento/dc_6a2e09f40dec

How to cite

Optimal Duration of Adjuvant Platinum-Etoposide in High-Risk Merkel Cell Carcinoma — Europe PMC PMID:42195135 — Europe PMC (en), https://europepmc.org/article/MED/42195135 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_6a2e09f40dec (Metraipolis archive dc_6a2e09f40dec, sha256 10659528d3101857c7b9acecb590e862d5110a8ffca4641e882ab55b632c552b)
BibTeX
@misc{dc6a2e09f40dec,
  title = {Optimal Duration of Adjuvant Platinum-Etoposide in High-Risk Merkel Cell Carcinoma — Europe PMC PMID:42195135},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42195135},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_6a2e09f40dec; sha256 10659528d3101857c7b9acecb590e862d5110a8ffca4641e882ab55b632c552b},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42195135. Agents can read the archived copy with the MCP tool read_document.